In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1+ dendritic epidermal cells

Int Immunol. 1992 Apr;4(4):487-91. doi: 10.1093/intimm/4.4.487.

Abstract

Interleukin-2 (IL-2), a crucial growth factor for mature T lymphocytes, is produced in fetal thymus under developmental control, although its biological significance remains unclear. We found that the two distinct subunits of the IL-2 receptor, i.e. the alpha-chain (IL-2R alpha) and the beta-chain (IL-2R beta), were expressed in an almost mutually exclusive fashion throughout fetal thymus ontogeny, and that the blockade of IL-2R beta, a signal transducing component of IL-2R, by administering a neutralizing mAb to IL-2R beta resulted in the complete and selective disappearance of Thy-1+ skin dendritic epidermal cells. Development of any other T cell subsets was uncompromised. This indicates that IL-2 plays a crucial role in the development of fetal V gamma 5+ cells and their descendants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antigens, Surface
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Female
  • Fetus / cytology
  • Fetus / immunology
  • Membrane Glycoproteins
  • Mice
  • Mice, Inbred C57BL
  • Pregnancy
  • Receptors, Interleukin-2 / antagonists & inhibitors*
  • Receptors, Interleukin-2 / immunology
  • Skin / cytology
  • Skin / immunology
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocyte Subsets / immunology
  • Thy-1 Antigens

Substances

  • Antibodies, Monoclonal
  • Antigens, Surface
  • Membrane Glycoproteins
  • Receptors, Interleukin-2
  • Thy-1 Antigens